RKVTF

RAKOVINA THERAPEUTICS INC by RAKOVINA THERAPEUTICS INC (RKVTF)

About RAKOVINA THERAPEUTICS INC by RAKOVINA THERAPEUTICS INC (RKVTF)

Rakovina Therapeutics, Inc. focuses on the development of new cancer treatments based on novel DNA-damage response technologies. It engages in developing precision medicines that selectively target and kill cancer cells using science to discover and advance innovative cancer treatments with the potential to improve patient outcomes across multiple tumor types. The company was founded on May 6, 2019 and is headquartered in Vancouver, Canada.

Details

Daily high
$0.04
Daily low
$0.04
Price at open
$0.04
52 Week High
$10.00
52 Week Low
$0.03
Market cap
3.6M
Dividend yield
0.00%
Volume
52,240
Avg. volume
39,970
P/E ratio
-1.07

RAKOVINA THERAPEUTICS INC by RAKOVINA THERAPEUTICS INC News

Details

Daily high
$0.04
Daily low
$0.04
Price at open
$0.04
52 Week High
$10.00
52 Week Low
$0.03
Market cap
3.6M
Dividend yield
0.00%
Volume
52,240
Avg. volume
39,970
P/E ratio
-1.07